Emmanuel Cherem, a 25-year-old gay man in Nigeria, tested positive for HIV two months after U.S. President Donald Trump's ...

The visit also served as an opportunity to explore how UNAIDS can support South Africa’s G20 Presidency and the country’s ...

The discontinuation of U.S. funding for HIV prevention under Trump's administration has severely impacted vulnerable ...

Last month, the health minister said that more than half a million previously diagnosed people with HIV have been started on treatment since the end of February. But can it really be, especially since ...

About 21 000 HIV patients have disappeared from Mpumalanga’s treatment system, yet officials remain unclear or deny the ...

General, Winnie Byanyima, has called for a drastic and transparent reduction in the cost of lenacapavir, a twice-yearly ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

Nigerian manufacturer Codix Bio is planning to produce millions of HIV and malaria test kits amid USAID funding cuts ...

The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that ...

The United States has approved a twice-a-year jab that almost entirely protects against HIV in what’s being hailed as a ...

Researchers at the University of Liverpool have indicated that this HIV prevention drug could be manufactured and rolled out at around $40 per person per year.

This is unacceptable in a country with one of the largest HIV treatment programmes in the world,"- Treatment Action ...